6th Pan Pacific Connective Tissue Societies Symposium

简介（由申请人提供）：第六届泛太平洋结缔组织协会研讨会将于2005年11月30日至12月5日在夏威夷大岛的威科罗亚希尔顿酒店举行。第六届研讨会的具体目的如下：(1)交流和分享有关已知和新的结缔组织成分的新结果，包括分子和结构生物学，组装和周转；体外和体内确定的细胞和发育功能和活动；细胞内机制和信号通路；在动物和人类的遗传性和获得性疾病中这些功能和过程的破坏；(2)加强科学家之间的互动与合作，特别是那些在环太平洋国家工作的科学家，他们对结缔组织研究的这些方面感兴趣；(3)为讨论新思想、新概念和新假设提供一个开放的论坛；(4)鼓励该领域的受训人员和新研究人员，提供一个方案，使他们与现有研究人员的互动最大化；(5)专门为新研究者提供展示数据的机会，从参与者那里获得最大的反馈，并组织研讨会；(6)促进抗体、细胞系和工程小鼠模型等试剂的交换；(7)汇集基础研究团体、临床研究团体、制药和生物技术公司的科学家；(8)营造有利于实现这些目标的氛围。由于几个原因，这次研讨会将特别重要。首先，我们组织了一个非常广泛的项目，涵盖了该领域当前的主要研究兴趣。其次，本次研讨会的计划强调了ECM成分如何在三维（3D）功能结缔组织中相互作用。因此，本次研讨会将代表这一领域的“前沿”研究，并将为相互作用的新后基因组时代的新兴概念做出贡献。第三，研讨会将突出几位西海岸科学家的重大贡献。第四，研讨会将是新研究者的一次重要会议。将有18个正式会议，每个会议由杰出的科学家主持，有时间由新的研究者进行额外的报告，2个海报会议和几个非正式研讨会。此外，将有机会进行非正式讨论和活动，以促进参与者之间的互动。

DESCRIPTION (provided by applicant): The 6th Pan Pacific Connective Tissue Societies symposium will be held November 30-December 5, 2005, at the Hilton Waikoloa on the Big Island of Hawaii. The specific aims of the 6th Symposium are the following: (1) To communicate and share new results concerning known as well as novel connective tissue constituents, including molecular and structural biology, assembly, and turnover; cellular and developmental functions and activities defined in vitro and in vivo; intracellular mechanism and signaling pathways; and the disruption of these functions and processes in hereditary and acquired diseases in animals and humans; (2) To increase interactions and collaborations between scientists, especially those working in the Pacific Rim countries, interested in these aspects of connective tissue research; (3) To provide an open forum for the discussion of new ideas, new concepts, and new hypotheses; (4) To encourage trainees and new investigators in this area by providing a program that will maximize their interactions with established investigators; (5) To specifically afford opportunities to new investigators to present their data, to receive maximal feedback from participants, and to organize workshops; (6) To facilitate the exchange of reagents such as antibodies, cell lines, and engineered mouse models; (7) To bring together scientists from basic research groups, clinical research groups, and pharmaceutical and biotechnology companies; (8) To create an atmosphere conducive to achieve these aims. This Symposium will be especially significant for several reasons. First, we have organized a program that is unusually broad and inclusive of major current research interests in this area. Second, the program of this Symposium emphasizes how ECM constituents interact in three-dimensional (3D) functioning connective tissues. This Symposium will therefore represent "cutting edge" research in this area and will contribute to emerging concepts in the new post-genomic era of the interactome. Third, the Symposium will highlight the significant contributions made by several West Coast scientists. Fourth, the Symposium will be a significant meeting for new investigators. There will be 18 formal sessions, each chaired by outstanding scientists with time for additional presentations by new investigators, 2 poster sessions, and several informal workshops. In addition, there will be opportunities for informal discussions and activities to promote interactions between participants.